Ajovy 225 MG/1.5 ML autoinject 1.5ML
Ended Awarded
- Contract number
- SPE2DB25FD16R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,017
Award facts
- Contract value 100% obligated
- $6,017.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,017.34 to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 mL auto-injector units. This firm fixed-price delivery order, issued on September 29, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 30, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract awards consistently demonstrate its capability to fulfill varied medical procurement requirements through open competition, with delivery orders involving firm fixed pricing that range from minimal transactions to substantial orders. The DLA is actively planning next-generation Pharmaceutical Prime Vendor Global Program contracts with the intent to make multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving military healthcare systems alongside the Defense Health Agency and other government healthcare organizations.
Quick answers
Who was awarded contract SPE2DB25FD16R?
SPE2DB25FD16R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FD16R worth?
The government has obligated $6,017 on SPE2DB25FD16R.
Is contract SPE2DB25FD16R an order under another contract?
Yes. SPE2DB25FD16R is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FD16R competed?
The extent of competition for SPE2DB25FD16R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award